← Browse by Condition
Medical Condition

her2 negative metastatic breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4
NCT05362760 Phase 4
Recruiting

Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

Enrollment
300 pts
Location
Germany, Switzerland
Sponsor
Prof. Wolfgang Janni
View Trial →